Results 251 to 260 of about 19,792 (277)

Hypolipidemic agent probucol (mechanisms of action, hypolipidemic effects, and clinical studies). Review

Pharmaceutical Chemistry Journal, 1995
A. A. Lyakishev, V. P. Lupanov, L. D. Smirnov   +2 more
openaire   +1 more source

Cardiotoxicity of anticancer treatments: Epidemiology, detection, and management

Ca-A Cancer Journal for Clinicians, 2016
Giuseppe Curigliano, Daniela Maria Cardinale, Susan Dent   +2 more
exaly  

Hepatocarcinogenesis of hypolipidemic agents

General Pharmacology: The Vascular System, 1981
openaire   +1 more source

An update on larynx cancer

Ca-A Cancer Journal for Clinicians, 2017
Kristin A Higgins, Nabil F Saba
exaly  

Appraisal of clofibrate as a hypolipidemic agent

American Heart Journal, 1968
openaire   +2 more sources

Nanooncology: The future of cancer diagnosis and therapy

Ca-A Cancer Journal for Clinicians, 2013
Sanjiv S Gambhir
exaly  

The current state of molecular testing in the treatment of patients with solid tumors, 2019

Ca-A Cancer Journal for Clinicians, 2019
Wafik S El-Deiry, Richard M Goldberg, Heinz-Josef Lenz   +2 more
exaly  

Immunotherapy of cancer in 2012

Ca-A Cancer Journal for Clinicians, 2012
Lisa H Butterfield, Ahmad A Tarhini
exaly  

Lung cancer: New biological insights and recent therapeutic advances

Ca-A Cancer Journal for Clinicians, 2011
Suresh S Ramalingam, Fadlo R Khuri
exaly  

[Hypolipidemic agents].

Revista clinica espanola, 1992
openaire   +1 more source